anti abcg2 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
95
Structured Review
Cell Signaling Technology Inc
anti abcg2
Anti Abcg2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+abcg2/ABCG2+XP+Rabbit+mAb/pm41898529-203-15-16
Average 95 stars, based on 137 article reviews
Anti Abcg2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+abcg2/ABCG2+XP+Rabbit+mAb/pm41898529-203-15-16
Average 95 stars, based on 137 article reviews
anti abcg2 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Western Blot:Article Title: Ticagrelor reverses multidrug resistance in breast cancer by inhibiting PI3K/AKT/mTOR pathway and suppressing ABCB1 expression and function. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: Lentiviruses encoding these constructs, as well as pLenti-Guide-GFP and pLenti-Guide-mCh (Addgene #185474) constructs containing an sgRNA targeting AAVS1 as a negative control, were produced and used to infect Cas9+ cells to generate cells expressing mCh+sgAAVS1, GFP+sgAAVS1, GFP+sgABCG2ex4KD, and GFP+sgABCG2ex6KD. pLenti-Guide vectors were generously provided by Dr. Daniel Durocher. .. ABCG2 KD and OE were confirmed with RT-qPCR using SYBR-green reagent and/or Western blotting using Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: Lentiviruses encoding these constructs, as well as pLenti-Guide-GFP and pLenti-Guide-mCh (Addgene #185474) constructs containing an sgRNA targeting AAVS1 as a negative control, were produced and used to infect Cas9+ cells to generate cells expressing mCh+sgAAVS1, GFP+sgAAVS1, GFP+sgABCG2ex4 KD , and GFP+sgABCG2ex6 KD . pLenti-Guide vectors were generously provided by Dr. Daniel Durocher. .. ABCG2 KD and OE were confirmed with RT-qPCR using SYBR-green reagent and/or Western blotting using Quantitative RT-PCR:Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: Lentiviruses encoding these constructs, as well as pLenti-Guide-GFP and pLenti-Guide-mCh (Addgene #185474) constructs containing an sgRNA targeting AAVS1 as a negative control, were produced and used to infect Cas9+ cells to generate cells expressing mCh+sgAAVS1, GFP+sgAAVS1, GFP+sgABCG2ex4KD, and GFP+sgABCG2ex6KD. pLenti-Guide vectors were generously provided by Dr. Daniel Durocher. .. ABCG2 KD and OE were confirmed with RT-qPCR using SYBR-green reagent and/or Western blotting using Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: Lentiviruses encoding these constructs, as well as pLenti-Guide-GFP and pLenti-Guide-mCh (Addgene #185474) constructs containing an sgRNA targeting AAVS1 as a negative control, were produced and used to infect Cas9+ cells to generate cells expressing mCh+sgAAVS1, GFP+sgAAVS1, GFP+sgABCG2ex4 KD , and GFP+sgABCG2ex6 KD . pLenti-Guide vectors were generously provided by Dr. Daniel Durocher. .. ABCG2 KD and OE were confirmed with RT-qPCR using SYBR-green reagent and/or Western blotting using Real-time Polymerase Chain Reaction:Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: Lentiviruses encoding these constructs, as well as pLenti-Guide-GFP and pLenti-Guide-mCh (Addgene #185474) constructs containing an sgRNA targeting AAVS1 as a negative control, were produced and used to infect Cas9+ cells to generate cells expressing mCh+sgAAVS1, GFP+sgAAVS1, GFP+sgABCG2ex4KD, and GFP+sgABCG2ex6KD. pLenti-Guide vectors were generously provided by Dr. Daniel Durocher. .. ABCG2 KD and OE were confirmed with RT-qPCR using SYBR-green reagent and/or Western blotting using Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: Lentiviruses encoding these constructs, as well as pLenti-Guide-GFP and pLenti-Guide-mCh (Addgene #185474) constructs containing an sgRNA targeting AAVS1 as a negative control, were produced and used to infect Cas9+ cells to generate cells expressing mCh+sgAAVS1, GFP+sgAAVS1, GFP+sgABCG2ex4 KD , and GFP+sgABCG2ex6 KD . pLenti-Guide vectors were generously provided by Dr. Daniel Durocher. .. ABCG2 KD and OE were confirmed with RT-qPCR using SYBR-green reagent and/or Western blotting using Blocking Assay:Article Title: Multi-Center “Replica Study” Challenges the Impact of Electronic Cigarette Aerosols on Cisplatin Resistance in Head and Neck Cancer Cells Article Snippet: .. After blocking the nonspecific sites, the membranes were incubated overnight at room temperature with the following primary antibodies resuspended in 5% BSA solution: anti-ATP7A (1:100; Santa Cruz Biotechnologies, Texas, USA, sc-376467), anti-CTR1 (1:40.000; Abcam, Massachusetts, USA, #ab129067), Incubation:Article Title: Multi-Center “Replica Study” Challenges the Impact of Electronic Cigarette Aerosols on Cisplatin Resistance in Head and Neck Cancer Cells Article Snippet: .. After blocking the nonspecific sites, the membranes were incubated overnight at room temperature with the following primary antibodies resuspended in 5% BSA solution: anti-ATP7A (1:100; Santa Cruz Biotechnologies, Texas, USA, sc-376467), anti-CTR1 (1:40.000; Abcam, Massachusetts, USA, #ab129067), Control:Article Title: Multi-Center “Replica Study” Challenges the Impact of Electronic Cigarette Aerosols on Cisplatin Resistance in Head and Neck Cancer Cells Article Snippet: .. After blocking the nonspecific sites, the membranes were incubated overnight at room temperature with the following primary antibodies resuspended in 5% BSA solution: anti-ATP7A (1:100; Santa Cruz Biotechnologies, Texas, USA, sc-376467), anti-CTR1 (1:40.000; Abcam, Massachusetts, USA, #ab129067), other:Article Title: ENOX2 (tNOX)–Associated Stemness in Oral Cancer Cells and Its Clinical Correlation in Head and Neck Tumors Article Snippet: The following antibodies were purchased from Article Title: Kaempferol attenuates hyperuricemia combined with gouty arthritis via urate transporters and NLRP3/NF-κB pathway modulation Article Snippet: |
